My watch list
my.bionity.com  
Login  

623 Current news from israel

rss
matching the following criteria

Prexton Therapeutics raises €8.7 million ($10 million) in a Series A round

26-Feb-2015

Prexton Therapeutics announced the closing of a Series A financing of €8.7 million ($10 million) co-led by Sunstone Capital and Ysios Capital. MS Ventures, the company's founding investor, will also participate. This first funding will help Prexton Therapeutics to develop novel small molecules ...

more

KUROS Announces grant of US Patent For its synthetic hydrogel technology

25-Feb-2015

Kuros Biosurgery AG announced that its patent application U.S.S.N 12/102,157 was issued and has been assigned U.S. Patent No. 8,961,947. The addition of this granted patent further strengthens Kuros’ position in synthetic in-situ forming biomaterials. Kuros is developing a portfolio of ...

more

Mechanical thrombectomy improves outcomes in acute ischemic stroke

24-Feb-2015

Stroke resulting from rupture or interruption of blood flow in brain vessels can lead to devastating consequences for patients, their families and society. Steady progress has been achieved in the last 20 years in stroke treatment through better prevention, establishment of stroke care units and ...

more

GlycoVaxyn AG sells its shares to GSK

17-Feb-2015

GSK, who was already a minority shareholder in GlycoVaxyn, acquires the company and its biological conjugation platform which may help it to develop a new generation of prophylactic vaccines against bacterial infections. GSK has today paid $190 million to purchase the remaining stake in the ...

more

image description
Game Theory Explains Social Interactions of Cancer Cells

02-Feb-2015

Researchers at the University of Basel and the University of East Anglia were able to predict the interactions of cancer cells using game theory. Their results have been published by the scientific journal PNAS. A tumor consists of a heterogeneous population of individual cells that compete for ...

more

Lonza Continues to Make Measurable Progress in Its Transformation

23-Jan-2015

In 2014 Lonza delivered expected CORE EBIT growth of 11% in constant exchange rates (CER) (+9% in reported currency), compared with 2013. Lonza’s overall results confirm the updated guidance communicated during the third-quarter update. Both of Lonza’s segments – Specialty Ingredients and ...

more

Damaged DNA amplified

20-Jan-2015

In the majority of cases, the onset of cancer is characterised by a minor change in a person's genetic material. A cell's DNA mutates in a particular area to the extent that the cell no longer divides in a controlled manner, but begins to grow uncontrollably. In many cases, this type of genetic ...

more

Evolva and L’Oréal reach first milestone in cosmetics ingredient project

09-Jan-2015

Evolva Holding SA announced the successful completion of the first part of its R&D collaboration with L’Oréal. The parties have agreed to move into the next phase of the multi-year programme. Under this collaboration, which started in February 2014, Evolva and L’Oréal are applying Evolva’s ...

more

Cytos exclusively licenses its VLP platform for the treatment of hepatitis B infections to OnCore Biopharma

08-Jan-2015

Cytos Biotechnology Ltd. announced that it executed an exclusive license agreement granting OnCore Biopharma, Inc. access to Cytos’ clinically validated virus like particle (VLP) platform for the use in the treatment and prevention of hepatitis B viral infections. Cytos also granted an option for ...

more

Smartphone thumb skills are altering our brains

29-Dec-2014

Typing, sweeping, swiping – Smartphone users have nimble thumbs and forefingers. However, it is not only finger dexterity that the daily use of mobile technology develops. As researchers from the Universities of Zurich and Fribourg demonstrate, it also alters the brain. The cortex quickly adapts ...

more

Page 1 From 63
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE